It also takes more time, energy, and money to get a biosimilar approved, compared to a generic medi…

"We will continue to focus on complex formulations - primarily injectables and oral solid dosage f…

The statement further said that the alliance is working closely with the International generic and…

Biosimilars are a bit more complicated than your average competing medicine: Unlike generics for ch…

"We are working closely with the International Generic and Biosimilar Medicines Association (IGPA),…

The savings of putting people on far less costly biosimilars - even just new patients who have neve…

London, Oct 1 (IANS) Researchers at the University of Oxford are starting a new study to explore th…

"Given that it was charging a lower price for Inflectra than J&J was charging for Remicade, Pfi…

Having more biosimilars in the US would be a big deal: It might be the best way to drive down the c…

Having more biosimilars on the market faster - without waiting six months - would be a big deal. It…

New Delhi, Dec 18 () Drug maker Lupin on Tuesday said its subsidiary Nanomi BV has completed divest…

That's not the case with something like a monoclonal antibody - a type of lab-produced protein that…

There's not a clear timeline on when Sandoz will be able to start putting Erelzi on the market, sin…

"When you have a small molecule like Lipitor, you know where every single atom is," Dennis Lanfear,…

"When you have a small molecule like Lipitor, you know where every single atom is," Dennis Lanfear,…

Among the drugs no longer covered by CVS are Gleevec, a drug used to treat a rare kind of leukemia …

But, Vilcek pointed out some of the complications that make biosimilars so different from generics,…

The name "biosimilar" refers to the fact that the new versions work in the exact same way as the or…

"These aren't generics, because you can't exactly replicate the different cell lines," Jerry Clewel…

Zarxio was approved because it was able to show that it was just as safe and effective as Neupogen.…